Agios Pharmaceuticals: CMO Gheuens Sarah Sells and Buys Shares on July 9.
ByAinvest
Friday, Jul 11, 2025 5:05 pm ET1min read
AGIO--
Agios Pharmaceuticals Inc. [AGIO] has announced that Chief Medical Officer Gheuens Sarah has recently executed transactions involving shares of the company's stock. Specifically, on July 9, 2025, Ms. Gheuens sold a total of 11,067 shares at a price of $37.93 per share. In addition, she sold an additional 847 shares at a price of $38.76 per share on the same date. Furthermore, Ms. Gheuens purchased a total of 11,914 shares at a price of $25.01 per share on July 9, 2025.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet